Adalimumab Prefilled Syringe for Psoriasis Treatment from Canada
Humira-brand adalimumab, a TNF inhibitor monoclonal antibody in 40mg prefilled syringes for retail sale, used prophylactically against autoimmune psoriasis flares. Classified in HTS 3002.15.00.91 as a biotechnological immunological product in measured retail doses.
Duty Rate — Canada → United States
0%
Rate breakdown
9903.03.030%Articles the product of any country, as provided for in subdivision (aa)(ii) of U.S. note 2 to this subchapter
Import Tips
• Submit FDA Import Alert 66-42 screening docs to avoid detention for unapproved biologics
• Verify serial numbers for anti-counterfeiting; common pitfall is incomplete pedigree records
• Confirm 'retail sale' packing with consumer instructions to differentiate from institutional bulk